Physician

Internal Medicine

Troyen Brennan works in the field of Internal Medicine. He went to medical school at Yale University School of Medicine. Yale University School of Medicine is a top medical college. Yale University School of Medicine is ranked 7 in research and 57 in primary care medicine He over the years received 1 awards: "Elected Member". Troyen Brennan is a published doctor. He has 100 publications published. The most current publication "Persistent opioid use following Cesarean delivery: patterns and predictors among opioid nave women."

Publications

---

• Patients' Satisfaction with and Preference for Telehealth Visits.
• Association Between Narrow Pharmacy Networks and Medication Adherence.
• Comparative effectiveness of generic versus brand-name antiepileptic medications.
• New Therapies in the Treatment of High Cholesterol: An Argument to Return to Goal-Based Lipid Guidelines.
• Initial choice of oral glucose-lowering medication for diabetes mellitus: a patient-centered comparative effectiveness study.
• The role of retail pharmacies in CVD prevention after the release of the ATP IV guidelines.
• Costs of new treatments for hepatitis C infection--reply.
• Quality of care at retail clinics for 3 common conditions.
• Cigarette Purchases at Pharmacies by Patients at High Risk of Smoking-Related Illness.
• New Expensive Treatments for Hepatitis C Infection.
• Did HEDIS Get it Right? Evaluating the Quality of a Quality Measure: Adherence to β-Blockers and Cardiovascular Outcomes After Myocardial Infarction.
• Time series analyses of the effect of FDA communications on use of prescription weight loss medications.
• Abusive prescribing of controlled substances--a pharmacy view.
• Full Prescription Coverage Versus Usual Prescription Coverage After Coronary Artery Bypass Graft Surgery: Analysis From the Post-Myocardial Infarction Free Rx Event an...
• Group-based Trajectory Models: A New Approach to Classifying and Predicting Long-Term Medication Adherence.
• Gender and racial disparities in adherence to statin therapy: A meta-analysis.
• An integrated pharmacy-based program improved medication prescription and adherence rates in diabetes patients.
• Trouble getting started: predictors of primary medication nonadherence.
• Generic drugs: the authors reply.
• The use of generic drugs in prevention of chronic disease is far more cost-effective than thought, and may save money.
• The implications of therapeutic complexity on adherence to cardiovascular medications.
• The consequences of requesting "dispense as written".
• Adherence to medication under mandatory and voluntary mail benefit designs.
• Physician perceptions about generic drugs.
• Medication adherence leads to lower health care use and costs despite increased drug spending.
• Healthcare information technology interventions to improve cardiovascular and diabetes medication adherence.
• The epidemiology of prescriptions abandoned at the pharmacy.
• How will health insurers respond to new rules under health reform?
• Defensive medicine and tort reform: a wide view.
• Rhode Island's novel experiment to rebuild primary care from the insurance side.
• Modes of delivery for interventions to improve cardiovascular medication adherence.
• A comprehensive case management program to improve palliative care.
• How can we make more progress in measuring physicians' performance to improve the value of care?
• The role of medical liability reform in federal health care reform.
• Incremental health care reform.
• Shifting terrain in the regulation of off-label promotion of pharmaceuticals.
• Do managed care plans' tiered networks lead to inequities in care for minority patients?
• Improving the Postmarket Surveillance of Total Joint Arthroplasty Devices.
• Changes in physician supply and scope of practice during a malpractice crisis: evidence from Pennsylvania.
• Sunshine laws and the pharmaceutical industry.
• Regulatory and judicial oversight of nonprofit hospitals.
• Missed and delayed diagnoses in the emergency department: a study of closed malpractice claims from 4 liability insurers.
• Physicians and drug representatives: exploring the dynamics of the relationship.
• Disclosure of medical injury to patients: an improbable risk management strategy.
• Missed and delayed diagnoses in the ambulatory setting: a study of closed malpractice claims.
• Analysis of surgical errors in closed malpractice claims at 4 liability insurers.
• Obesity--the new frontier of public health law.
• Claims, errors, and compensation payments in medical malpractice litigation.
• Health industry practices that create conflicts of interest: a policy proposal for academic medical centers.
• "Health courts" and accountability for patient safety.
• Concierge care and the future of general internal medicine.
• Recertification for internists--one "grandfather's" experience.
• Effects of a malpractice crisis on specialist supply and patient access to care.
• Legal concerns and the influenza vaccine shortage.
• Accidental deaths, saved lives, and improved quality.
• Advising patients about patient safety: current initiatives risk shifting responsibility.
• Specialty versus community hospitals: what role for the law?
• Defensive medicine among high-risk specialist physicians in a volatile malpractice environment.
• Fostering rational regulation of patient safety.
• Iatrogenic events resulting in intensive care admission: frequency, cause, and disclosure to patients and institutions.
• Overbilling vs. downcoding--the battle between physicians and insurers.
• Integration of an academic medical center and a community hospital: the Brigham and Women's/Faulkner hospital experience.
• Race and family history assessment for breast cancer.
• The swinging pendulum: the Supreme Court reverses course on ERISA and managed care.
• Financial conflicts of interest in physicians' relationships with the pharmaceutical industry--self-regulation in the shadow of federal prosecution.
• The role of physician specialty board certification status in the quality movement.
• Allergic to generics.
• Caring for patients in a malpractice crisis: physician satisfaction and quality of care.
• A middle ground on public accountability.
• Heal the law, then health care.
• Communication factors in the follow-up of abnormal mammograms.
• The pharmaceutical industry versus Medicaid--limits on state initiatives to control prescription-drug costs.
• Physician-citizens--public roles and professional obligations.
• Decision making and satisfaction with care in the pediatric intensive care unit: findings from a controlled clinical trial.
• Hospitals' behavior in a tort crisis: observations from Pennsylvania.
• Due process in investigations of research misconduct.
• Conflict in the care of patients with prolonged stay in the ICU: types, sources, and predictors.
• Nature of conflict in the care of pediatric intensive care patients with prolonged stay.
• Patient safety and medical malpractice: a case study.
• Results of a clinical trial on care improvement for the critically ill.
• The rise of litigation in human subjects research.
• The new medical malpractice crisis.
• Analysis of errors reported by surgeons at three teaching hospitals.
• Predictors and outcomes of frequent emergency department users.
• Reduced medicolegal risk by compliance with obstetric clinical pathways: a case--control study.
• The Leapfrog standards: ready to jump from marketplace to courtroom?
• Hospital disclosure practices: results of a national survey.
• Medical monitoring for pharmaceutical injuries: tort law for the public's health?
• Risk factors for retained instruments and sponges after surgery.
• Impact of the National Practitioner Data Bank on resolution of malpractice claims.
• Physicians' professional responsibility to improve the quality of care.
• Editorial: renewing professionalism in medicine: the physician charter.
• The reliability of medical record review for estimating adverse event rates.
• Luxury primary care--market innovation or threat to access?
• Direct-to-consumer marketing of high-technology screening tests.
• Inconsistent report cards: assessing the comparability of various measures of the quality of ambulatory care.
• Influence of body weight on patients' satisfaction with ambulatory care.
• Persistent opioid use following Cesarean delivery: patterns and predictors among opioid naïve women.
• Impact of a transition to more restrictive drug formulary on therapy discontinuation and medication adherence.

Schools

---

• Yale University

Doctors Specialties

---

• Internal Medicine

Accepted Insurances

---

Awards

---

• Elected Member

Education

---

• Massachusetts General Hospital
• Yale University School of Medicine

Helpful Reviews

---

Give Anonymous Review

Similar Doctors

---

	Patrick R. Levesque
	Dr. Khaled S. Sheikh Qasem, MD This Doctor is OpenDoctor Recommended.
	Dr. Jibran Khan, MD This Doctor is OpenDoctor Recommended.
	Dr. Greigstone M. Yearwood, MD This Doctor is OpenDoctor Recommended.
	Dr. Ayman Z. Attia-Alla, MD This Doctor is OpenDoctor Recommended.
	Dr. Khaled A. Qasem, MD

---

Doctor Directory | TOS | twitter | FB | Angel | blog